![]() |
|
|
Vol. 297, Issue 2, 563-572, May 2001
Institut National de la Santé et de la Recherche
Médicale, Université Paul Sabatier, Toulouse, France (N.M.,
E.F., F.S., P.R., D.P., C.C.); Departament de Bioquímica i
Biologia Molecular, Facultat de Medicina, Universitat Autonoma de
Barcelona, Barcelona, Spain (J.-M.L., M.U.); and Departament de
Bioquímica i Biologia Molecular, Facultat de Biologia,
Universitat de Barcelona, Barcelona, Spain (L.M., A.Z.)
Semicarbazide-sensitive amine oxidases (SSAO) are widely distributed
enzymes scavenging biogenic or exogenous amines and generating hydrogen
peroxide. We asked whether human adipose tissue could express SSAO.
Since hydrogen peroxide exhibits pharmacological insulin-like effects,
we also tested whether its endogenous production by SSAO could mimic
several insulin effects on adipocytes, such as stimulation of glucose
uptake and inhibition of lipolysis. The benzylamine oxidation by human
adipose tissue was inhibited by semicarbazide or hydralazine and
resistant to pargyline or selegiline. It was due to an SSAO activity
localized in adipocyte membranes. A protein of 100-kDa and a 4-kb mRNA
corresponding to SSAO were identified in either mammary or abdominal
subcutaneous fat depots. In isolated adipocytes, SSAO oxidized
similarly benzylamine and methylamine that dose dependently stimulated
glucose transport in a semicarbazide-sensitive manner. Antioxidants
also inhibited the benzylamine and methylamine effects. Moreover, the
ability of diverse substrates to be oxidized by adipocytes was
correlated to their effect on glucose transport. Benzylamine and
methylamine exerted antilipolytic effects with a maximum attained at 1 mM. These results show that human adipocytes express a membrane-bound SSAO that not only readily oxidizes exogenous amines and generates H2O2, but that also interplays with glucose and
lipid metabolism by exerting insulin-like actions. Based on these
results and the fact that variations in plasma levels of the soluble
form of SSAO have been previously reported in diabetes, we propose that
determination of adipocyte SSAO, feasible on subcutaneous
microbiopsies, could bring relevant information in pathologies such as
obesity or diabetes.
This article has been cited by other articles:
![]() |
A. Galinier, A. Carriere, Y. Fernandez, C. Carpene, M. Andre, S. Caspar-Bauguil, J.-P. Thouvenot, B. Periquet, L. Penicaud, and L. Casteilla Adipose Tissue Proadipogenic Redox Changes in Obesity J. Biol. Chem., May 5, 2006; 281(18): 12682 - 12687. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Iglesias-Osma, M. J. Garcia-Barrado, V. Visentin, M. F. Pastor-Mansilla, S. Bour, D. Prevot, P. Valet, J. Moratinos, and C. Carpene Benzylamine Exhibits Insulin-Like Effects on Glucose Disposal, Glucose Transport, and Fat Cell Lipolysis in Rabbits and Diabetic Mice J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1020 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vega, P. Chacon, J. Monteseirin, R. El Bekay, M. Alvarez, G. Alba, J. Conde, J. Martin-Nieto, F. J. Bedoya, E. Pintado, et al. A new role for monoamine oxidases in the modulation of macrophage-inducible nitric oxide synthase gene expression J. Leukoc. Biol., June 1, 2004; 75(6): 1093 - 1101. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Yu, M. Wang, H. Fan, Y. Deng, and D. Gubisne-Haberle Involvement of SSAO-mediated deamination in adipose glucose transport and weight gain in obese diabetic KKAy mice Am J Physiol Endocrinol Metab, April 1, 2004; 286(4): E634 - E641. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Smith, F. Bai, C. Charbonneau, L. Janderova, and G. Argyropoulos A Promoter Genotype and Oxidative Stress Potentially Link Resistin to Human Insulin Resistance Diabetes, July 1, 2003; 52(7): 1611 - 1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abella, L. Marti, M. Camps, M. Claret, J. Fernandez-Alvarez, R. Gomis, A. Guma, N. Viguerie, C. Carpene, M. Palacin, et al. Semicarbazide-Sensitive Amine Oxidase/Vascular Adhesion Protein-1 Activity Exerts an Antidiabetic Action in Goto-Kakizaki Rats Diabetes, April 1, 2003; 52(4): 1004 - 1013. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mercier, M. Moldes, K. E. Hadri, and B. Feve Regulation of Semicarbazide-Sensitive Amine Oxidase Expression by Tumor Necrosis Factor-alpha in Adipocytes: Functional Consequences on Glucose Transport J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1197 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Morin, V. Visentin, D. Calise, L. Marti, A. Zorzano, X. Testar, P. Valet, Y. Fischer, and C. Carpene Tyramine Stimulates Glucose Uptake in Insulin-Sensitive Tissues in Vitro and in Vivo via Its Oxidation by Amine Oxidases J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1238 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Salmi, C. Stolen, P. Jousilahti, G. G. Yegutkin, P. Tapanainen, T. Janatuinen, M. Knip, S. Jalkanen, and V. Salomaa Insulin-Regulated Increase of Soluble Vascular Adhesion Protein-1 in Diabetes Am. J. Pathol., December 1, 2002; 161(6): 2255 - 2262. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Visentin, N. Morin, E. Fontana, D. Prevot, J. Boucher, I. Castan, P. Valet, D. Grujic, and C. Carpene Dual Action of Octopamine on Glucose Transport into Adipocytes: Inhibition via beta 3-Adrenoceptor Activation and Stimulation via Oxidation by Amine Oxidases J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 96 - 104. [Abstract] [Full Text] [PDF] |
||||